1. Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison;Lancet Infect Dis,2020
2. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients;Okba;Emerg Infect Dis,2020
3. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial;Folegatti;Lancet,2020
4. Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels;medRxiv,2020
5. Convalescent plasma therapy for the treatment of patients with COVID-19: assessment of methods available for antibody detection and their correlation with neutralising antibody levels;Harvala;MedRxiv,2020